Epigenetic Analysis of Body Fluids and Tumor Tissues: Application of a Comprehensive Molecular Assessment for Early-Stage Breast Cancer Patients
Authors:
- 1 September 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1075 (1) , 211-221
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Detection and Characterization of Circulating Microsatellite‐DNA in Blood of Patients with Breast CancerAnnals of the New York Academy of Sciences, 2004
- Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patientsOncogene, 2004
- DNA methylation and breast carcinogenesisOncogene, 2002
- Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancersBritish Journal of Cancer, 2001
- Methylation and Silencing of the Retinoic Acid Receptor- 2 Gene in Breast CancerJNCI: Journal of the National Cancer Institute, 2000
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrowCancer, 1991
- A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.Journal of Clinical Oncology, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989